Dropdown items
My Academies

Personal Library

Account settings

Biological Effectors of Social Determinants of Health in Cancer: Identification and Mitigation: Proceedings of a Workshop (2025)

Chapter: Appendix B: Workshop Agenda

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.

Previous chapter Next chapter
Page of 76
Search this publication

Previous Chapter: Appendix A: Statement of Task

Page 69 Cite

Suggested Citation: "Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2025. Biological Effectors of Social Determinants of Health in Cancer: Identification and Mitigation: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/28034.

Appendix B

Workshop Agenda

MARCH 20, 2024

8:30 am	Welcome and Workshop Overview Planning Committee Co-Chairs: Chanita Hughes-Halbert, University of Southern California Stanton Gerson, Case Western Reserve University
9:00 am	Session 1: Multi-Level Approach to Understanding Biological Effectors and Social Determinants of Health Co-Moderators: Chanita Hughes-Halbert, University of Southern California Stanton Gerson, Case Western Reserve University
	Overview of Health Disparities in Cancer Otis Brawley, Johns Hopkins University
	Social Determinants of Health Reginald Tucker-Seeley, Health Equity Strategies and Solutions
	Overview of Biological Effectors of SDOH and Influence on Cancer Risk and Outcomes Lauren McCullough, Rollins School of Public Health, Emory University

Page 70 Cite

	Panel Discussion Include speakers and Beverly Rogers, From Momma’s House
10:30 am	Break
10:45 am	Session 2: Review of Emerging Research on SDOH, Biological Pathways, and Cancer Outcomes Co-Moderators: Scarlett Lin Gomez, University of California, San Francisco Lawrence Shulman, University of Pennsylvania
	What Can the Health Care Sector Do About Social Conditions? The NASEM 5A Framework Laura Gottlieb, Social Interventions Research and Evaluation Network (SIREN), University of California, San Francisco (Virtual)
	Allostatic Load and Breast Cancer: Tracing Social Determinant of Health Pathways Samilia Obeng-Gyasi, The Ohio State University
	An Interplay Between Social and Structural Determinants of Health and Stress in Cancer Adana Llanos, Mailman School of Public Health, Columbia University Irving Medical Center
	Emerging Genomic Pathways for Social Risk Exposure and Health Outcomes Ruth Carlos, University of Michigan
	Panel Discussion Include speakers and Wayne Lawrence, National Cancer Institute Alma McCormick, Messengers for Health (Virtual)
12:15 pm	Break

Page 71 Cite

1:15 pm	Session 3: Improving the Development and Validation of Biomarkers and Models Assessing the Effects of SDOH on Biological Pathways and Patient Outcomes Co-Moderators: Smita Bhatia, University of Alabama at Birmingham (Virtual) Robert Winn, Virginia Commonwealth University
	Global Networks Approaches Clayton Yates, Johns Hopkins University
	Chronic Social Stressors and Breast Cancer Biology: Laboratory Insights Suzanne Conzen, University of Texas Southwestern Medical Center
	Cancer Prevention and Biomarker Development Victoria Seewaldt, City of Hope
	The Biological Influences of Social Determinants of Health: Challenges, Surprises, and Complexities Michele Evans, National Institute on Aging
	Panel Discussion Include speakers and Andrea Ferris, LUNGevity Foundation
3:00 pm	Break
3:15 pm	Session 4: Opportunities to Advance Progress on Biological Effectors of SDOH Research Co-Moderators: Olive Mbah, Flatiron Health Stanton Gerson, Case Western Reserve University
3:15 pm	Innovations in Population-Based Research Approaches to Advance Endometrial Cancer Equity: The Carolina Endometrial Cancer Study Victoria Bae-Jump, University of North Carolina at Chapel Hill

Page 72 Cite

	SDOH at the Intersection of Cancer Health Equity Research and Real-World Evidence Generation Olive Mbah, Flatiron Health
	Equity in Access to Oncology Biomarker Testing Gregory Vidal, West Cancer Center
	Minimizing the Impact of Biological and Social Drivers on Cancer Disparities: Prostate Cancer Timothy Rebbeck, Dana-Farber Cancer Institute, Harvard University
	Panel Discussion Include speakers and Stanley Frencher, Martin Luther King, Jr. Community Hospital Karriem Watson, All of Us Research Program
5:00 pm	Poster Session
7:00 pm	Adjourn

MARCH 21, 2024

8:30 am	Session 5: Policy Opportunities to Address SDOH on Cancer Outcomes and Improve the Evidence Base on the Impact of SDOH on Biological Outcomes Co-Moderators: Cathy Bradley, Colorado School of Public Health Gwen Darien, Patient Advocate Foundation
	National Policy Batsheva Honig, Centers for Medicare & Medicaid Services Innovation Center (Virtual)
	Institutional Policy and Implementation Cardinale Smith, Mount Sinai Health System (Virtual)
	Research Perspective Oluwadamilola “Lola” Fayanju, University of Pennsylvania Perelman School of Medicine

Page 73 Cite

	National Consumer Advocacy Perspective Staci Lofton, Families USA (Virtual)
	Panel Discussion Include speakers and Christopher Cogle, University of Florida and Florida Medicaid Jasmine McDonald, Columbia University Irving Medical Center Lawrence Shulman, University of Pennsylvania
10:15 am	Break
10:30 am	Session 6: Concluding Discussion and Next Steps Co-Moderators: Chanita Hughes-Halbert, University of Southern California Stanton Gerson, Case Western Reserve University
10:30 am	Panelists: Session 1: Chanita Hughes-Halbert and Stanton Gerson Session 2: Scarlett Lin Gomez and Lawrence Shulman Session 3: Smita Bhatia (Virtual) and Robert Winn Session 4: Olive Mbah and Stanton Gerson Session 5: Cathy Bradley and Gwen Darien
11:30 am	Adjourn